Paul B. Rothman | |
|---|---|
 |
Dr. Paul B. Rothman (born 1958) is the former Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty, vice president for medicine at Johns Hopkins University, and former chief executive officer of Johns Hopkins Medicine. [1] [2] As dean and CEO, Dr. Rothman oversaw both the School of Medicine and the Johns Hopkins Health System, which together encompass six hospitals, hundreds of faculty and community physicians and a self-funded health plan. [3]
Dr. Rothman was born in New York City in 1958 and grew up in Bayside, Queens. He began his research career as an undergraduate at the Massachusetts Institute of Technology, where he studied E. coli DNA repair under Graham C. Walker. [4] He was also captain of the varsity crew team. He completed his B.S. in biology in 1980 and was elected to Phi Beta Kappa. He then entered medical school at Yale University. While at Yale, Dr. Rothman studied T cell subsets in the lab of Leonard Chess at Columbia University. He received his medical degree in 1984, earning a place in the Alpha Omega Alpha Medical Honor Society. [3]
He went on to a medical residency and rheumatology fellowship at Columbia-Presbyterian Medical Center in New York City before joining the medical faculty of the Columbia University College of Physicians and Surgeons in 1986. [5] There, he also completed a postdoctoral biochemistry fellowship with Frederick W. Alt, a Howard Hughes Medical Institute investigator, studying immunoglobulin class-switch recombination. At Columbia, Dr. Rothman was appointed the Richard J. Stock Professor of Medicine (Immunology) and Microbiology and chief of the pulmonary, allergy and critical care division. [1]
A molecular immunologist, Dr. Rothman's research focused on immune system molecules called cytokines. He investigated the role these molecules play in the normal development of blood cells, in addition to the abnormal blood-cell development that leads to leukemia. He also studied the function of cytokines in immune system responses to allergies and asthma. The National Institutes of Health consistently funded his work. [6]
In 2004, Dr. Rothman accepted a position as head of internal medicine at the Carver College of Medicine at the University of Iowa. In 2008, he was named dean of the Carver College of Medicine and leader of its clinical practice plan, a role in which he served for four years. [7] In 2012, he became the 14th dean of the Johns Hopkins School of Medicine and the second CEO of Johns Hopkins Medicine. [1]
Dr. Rothman is on the Board of Directors of Merck and Company, as well as the King Faisal Specialist Hospital & Research Centre in Saudi Arabia.
Dr. Rothman is a member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Society for Clinical Investigation. He has served as president of the Association of American Physicians and the Society of Medical Administrators, and was elected as a Fellow of the American Association for the Advancement of Sciences.
He is married to Dr. Frances Meyer, a gastroenterologist.
The National Academy of Medicine (NAM), known as the Institute of Medicine (IoM) until 2015, is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC).
Baruj Benacerraf was a Venezuelan-American immunologist, who shared the 1980 Nobel Prize in Physiology or Medicine for the "discovery of the major histocompatibility complex genes which encode cell surface protein molecules important for the immune system's distinction between self and non-self." His colleagues and shared recipients were Jean Dausset and George Davis Snell.
The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.
Edward D. Miller Jr. was the Frances Watt Baker, M.D. and Lenox D. Baker Jr., M.D. Dean of the Medical Faculty at Johns Hopkins University and the Chief Executive Officer of Johns Hopkins Medicine from 1997 to 2012.
Charles Alderson Janeway, Jr. (1943–2003) was a noted immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an Howard Hughes Medical Institute Investigator.
Vanderbilt University School of Medicine (VUSM) is the graduate medical school of Vanderbilt University, a private research university located in Nashville, Tennessee. The School of Medicine is primarily housed within the Eskind Biomedical Library which sits at the intersection of the Vanderbilt University and Vanderbilt University Medical Center (VUMC) campuses and claims several Nobel laureates in the field of medicine. Through the Vanderbilt Health Affiliated Network, VUSM is affiliated with over 60 hospitals and 5,000 clinicians across Tennessee and five neighboring states which manage more than 2 million patient visits each year. As the home hospital of the medical school, VUMC is considered one of the largest academic medical centers in the United States and is the primary resource for specialty and primary care in hundreds of adult and pediatric specialties for patients throughout the Mid-South.
John J. O'Shea is an American physician and immunologist.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Hugh O'Neill McDevitt ForMemRS was an immunologist and Professor of Microbiology and Immunology at Stanford University School of Medicine.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
Patricia Charache was a physician specializing in infectious disease and microbiology. She was a faculty member at the Johns Hopkins University School of Medicine for more than 50 years, retiring as a Distinguished Professor Emeritus of Pathology, Medicine, and Oncology.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Katrina Alison Armstrong is an American internist. She is the chief executive officer of the Columbia University Irving Medical Center and Dean of the Faculties of Health Sciences and the Columbia University Vagelos College of Physicians and Surgeons. Armstrong is the first woman to lead Columbia's medical school and medical center. She was the first woman to hold the position of Physician-in-Chief at Massachusetts General Hospital and was elected to the National Academy of Medicine in 2013 and the American Academy of Arts and Sciences in 2020.
Dr. Michael J. Lenardo, is the chief of the Molecular Development and Immune System Section and the founder and co-Director of the Clinical Genomics Program at the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH). Trained as a geneticist, molecular biologist, and immunologist, his research examines how cells of the immune system defend themselves against various pathogens, including viruses and bacteria. His research has investigated genetic abnormalities in the immune system, mechanisms of cell death, genetic diseases of immune homeostasis and autoimmunity, and development of novel diagnostics and therapeutics for diseases of the immune system. Lenardo's contributions to science and medicine have shown the possibilities of genomic research in developing precision medicine diagnoses and treatments for disease in humans. In 2006 he was appointed Officer of the Most Excellent Order of the British Empire (O.B.E.) by Queen Elizabeth II. In 2019 he was inducted into the National Academies of Sciences and the National Academy of Medicine, considered among the highest honors awarded to a U.S scientist and medical researcher respectively.
Jordan Scott Orange is an American pediatric immunologist. Orange is credited with defining a new class of diseases known as natural killer cell deficiencies.
Dennis L. Kasper is an American microbiologist and immunologist, and the William Ellery Channing Professor of Medicine and Professor of Immunology at Harvard Medical School. He leads the Kasper Laboratory within the Blavatnik Institute in the Department of Immunology at Harvard Medical School. He was also executive dean for academic programs at Harvard Medical School and director of the Channing Laboratory Department of Medicine at Brigham and Women's Hospital.